Ezetimibe Phase IV Clinical Study in Patients With Hypercholesterolemia
Phase of Trial: Phase IV
Latest Information Update: 16 May 2017
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin; Rosuvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck & Co; Schering-Plough
- 10 Jun 2017 Biomarkers information updated
- 16 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.